Non Invasive Brain Stimulation Treatment for CLBP (NIBSTCLBP)
Primary Purpose
Chronic Low Back Pain (CLBP)
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
NIBS system for evaluation and treatment utilizing non invasive brain stimulation
Sponsored by
About this trial
This is an interventional treatment trial for Chronic Low Back Pain (CLBP)
Eligibility Criteria
Inclusion Criteria:
- Age 18 to 80
- CLBP as defined by the European guidelines.
- low back pain first week average NPRS>4.
Exclusion Criteria:
- Acute low back pain (duration of less than 6 months) first week average NPRS> 4
- Neurological illness causing structural brain damage (e.g. Stroke, TIA)
- Psychiatric disease other than mood disorders
- Current chronic use of medications with pro-epileptic properties
- Known alcohol dependency
- Use of alcohol within the previous 24 hours
- History of loss of consciousness
- Epilepsy or epilepsy in a first degree relative
- Medical implants
- Pregnancy
- Illicit drug use or within the previous month
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Sham Comparator
Arm Label
Fully active treatement
partially active
Arm Description
first 2.5 weeks will receive sham treatment followed by active
Outcomes
Primary Outcome Measures
Change in CLBP on a 0-10 Numerical Pain Rating Scale (NPRS)
Secondary Outcome Measures
Change From Baseline in Sleep Quality (0-10 Numerical Rating Scale Scores)
Change CLBP quality of life -Roland-Morris questionnaire
Full Information
NCT ID
NCT02615418
First Posted
November 23, 2015
Last Updated
November 26, 2015
Sponsor
NIBS NeuroScience Technologies
1. Study Identification
Unique Protocol Identification Number
NCT02615418
Brief Title
Non Invasive Brain Stimulation Treatment for CLBP
Acronym
NIBSTCLBP
Official Title
A Novel Non Invasive Brain Stimulation,tDCS Based Treatment for Chronic Low Back Pain (CLBP)-Sourasky Medical Center-Tel Aviv
Study Type
Interventional
2. Study Status
Record Verification Date
November 2015
Overall Recruitment Status
Unknown status
Study Start Date
January 2016 (undefined)
Primary Completion Date
January 2017 (Anticipated)
Study Completion Date
July 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
NIBS NeuroScience Technologies
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This trial is designed to preliminary evaluate the efficacy and safety of NIBS system for treatment of chronic low back pain (CLBP) (over 6 months). The trial is of a double blind sham controlled partial crossover design and will involve 2 weekly treatments and evaluations for 6 weeks, with 6 weeks follow-up. The goal of the study is to 1. Asses the CLBP change immediate and long term effect for the trial duration and follow-up. 2. Asses quality of life improvement as measure by sleep quality and questioners. 3. Asses long term neuronal changes or lack thereof in treated and untreated subjects.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Low Back Pain (CLBP)
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Fully active treatement
Arm Type
Active Comparator
Arm Title
partially active
Arm Type
Sham Comparator
Arm Description
first 2.5 weeks will receive sham treatment followed by active
Intervention Type
Device
Intervention Name(s)
NIBS system for evaluation and treatment utilizing non invasive brain stimulation
Primary Outcome Measure Information:
Title
Change in CLBP on a 0-10 Numerical Pain Rating Scale (NPRS)
Time Frame
Baseline to week 6 .
Secondary Outcome Measure Information:
Title
Change From Baseline in Sleep Quality (0-10 Numerical Rating Scale Scores)
Time Frame
Baseline to 6 weeks
Title
Change CLBP quality of life -Roland-Morris questionnaire
Time Frame
Baseline to 6 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 18 to 80
CLBP as defined by the European guidelines.
low back pain first week average NPRS>4.
Exclusion Criteria:
Acute low back pain (duration of less than 6 months) first week average NPRS> 4
Neurological illness causing structural brain damage (e.g. Stroke, TIA)
Psychiatric disease other than mood disorders
Current chronic use of medications with pro-epileptic properties
Known alcohol dependency
Use of alcohol within the previous 24 hours
History of loss of consciousness
Epilepsy or epilepsy in a first degree relative
Medical implants
Pregnancy
Illicit drug use or within the previous month
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Iftach Dolev, PhD
Email
iftach@nibs.co.il
12. IPD Sharing Statement
Learn more about this trial
Non Invasive Brain Stimulation Treatment for CLBP
We'll reach out to this number within 24 hrs